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Abstract
Background: Assessing pain in neonates is challenging because full-term and preterm neonates of different
gestational ages (GAs) have widely varied reactions to pain. We validated the Bernese Pain Scale for Neonates
(BPSN) by testing its use among a large sample of neonates that represented all GAs.
Methods: In this prospective multisite validation study, we assessed 154 neonates between 24 2/7 and 41 4/7
weeks GA, based on the results of 1–5 capillary heel sticks in their first 14 days of life. From each heel stick, we
produced three video sequences: baseline; heel stick; and, recovery. Five blinded nurses rated neonates’ pain
responses according to the BPSN. The underlying factor structure of the BPSN, interrater reliability, concurrent
validity with the Premature Infant Pain Profile-Revised (PIPP-R), construct validity, sensitivity and specificity, and the
relationship between behavioural and physiological indicators were explored. We considered GA and gender as
individual contextual factors.
Results: The factor analyses resulted in a model where the following behaviours best fit the data: crying; facial
expression; and, posture. Pain scores for these behavioural items increased on average more than 1 point during
the heel stick phases compared to the baseline and recovery phases (p < 0.001). Among physiological items, heart
rate was more sensitive to pain than oxygen saturation. Heart rate averaged 0.646 points higher during the heel
stick than the recovery phases (p < 0.001). GA increased along with pain scores: for every additional week of
gestation, the average increase of behavioural pain score was 0.063 points (SE = 0.01, t = 5.49); average heart rate
increased 0.042 points (SE = 0.01, t = 6.15). Sensitivity and specificity analyses indicated that the cut-off should
increase with GA. Modified BPSN showed good concurrent validity with the PIPP-R (r = 0.600–0.758, p < 0.001).
Correlations between the modified behavioural subscale and the item heart rate were low (r = 0.102–0.379).
Conclusions: The modified BPSN that includes facial expression, crying, posture, and heart rate is a reliable and
valid tool for assessing acute pain in full-term and preterm neonates, but our results suggest that adding different
cut-off points for different GA-groups will improve the BPSN’s clinical usefulness.
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Background
Acute painful status in preverbal infants is assessed and
interpreted by observing measurable behavioural and
physiological indicators. An infant who undergoes an in-
vasive procedure may react to pain that is not caused
solely by the painful stimulus [1, 2]. Incorporating individ-
ual contextual factors, like gestational age (GA) and gen-
der, into pain assessment tools might make them more
accurate [3, 4]. The physiological and behavioural dimen-
sions of pain in neonates are measured by several multidi-
mensional pain assessment tools developed over the last
three decades [4–6], but experts agree that behavioural,
physiological and cortical measures of pain do not con-
verge to reliably depict and assess the phenomenon of
pain in such a vulnerable population [7, 8]. Discrepancies
and low-to-moderate associations between behavioural
(e.g., facial expression) and physiological (e.g., changes in
heart rate) indicators of pain [9–12] have sparked ongoing
debate about the appropriate dimensionality of pain scales
[7]. Infants may also display nonspecific physiological and
behavioural pain indicators during stressful experiences
that are not painful, which makes it more challenging to
accurately assess pain in neonates [13, 14].
Many pain assessment tools are used in neonatal in-
tensive care unit (NICU) settings. Most add behavioural
and physiological indicators to a summary score that is
then measured against a cut-off that separates pain from
no pain [4]. Rigorous psychometric testing has been ap-
plied only to a few [15] (e.g., the Premature Infant Pain
Profile [16]). Most were validated for a specific GA in
tests that assessed acute pain in full-term and healthy
preterm infants with higher GA [4]. However, neurode-
velopment and the associated ability to react to painful
stimulus varies greatly among early and late preterm in-
fants and full-term neonates: neonates with lower GA
express less behavioural pain than more mature neo-
nates [17–22]. In neurologically impaired and very ill ne-
onates, and in neonates on medications (e.g., sedatives),
pain may be faintly expressed, or not at all [13, 23].
The Bernese Pain Scale for Neonates (BPSN) is a
multidimensional pain assessment tool that includes
seven subjective items (sleeping, crying, consolation, skin
colour, facial expression, posture, and breathing) and
two physiological items (changes in heart rate and oxy-
gen saturation) [24]. The BPSN has been used by clini-
cians since 2001; 46% of Swiss NICUs rely on this tool
to assess pain in neonates [25]. The results of the first
validation study in the year 2004 suggested that the
BPSN is a valid and reliable scale for assessing acute
pain in full-term and preterm neonates with different
GAs [24]. However, clinical experts have said the tool is
less useful for assessing pain in extremely preterm neo-
nates who, for example, always score very low. This
feedback and the increasing scientific evidence which
indicates that neonates’ pain reaction is influenced by in-
dividual contextual factors [1] have motivated us to
re-evaluate the tool with sophisticated psychometric
tests to assess its accuracy across all GAs.
This study is the first part of a comprehensive BPSN
validation and extension study, designed to develop a
modified version of the BPSN that includes relevant in-
dividual contextual factors in pain assessment. In this
first part, we evaluated the BPSN with psychometric
tests. The second part of the study will explore the influ-
ence of individual contextual factors (e.g., medication, or
number of previous painful experiences) on variability in
pain reactions across repeated measurement points.
We used psychometric tests to determine the applic-
ability of the BPSN across neonates who ranged from 24
to 42 weeks of GA. We evaluated interrater reliability,
the underlying factor structure of the BPSN, and the in-
ternal consistency of the scale. We also assessed concur-
rent validity with the Premature Infant Pain Profile-
Revised (PIPP-R; [26]), construct validity, specificity and
sensitivity, and determined the relationship between
behavioural and physiological indicators of pain. GA
groups and gender were considered as individual con-
textual factors.
Based on the results of the first validation study of the
BPSN [24], we hypothesized that the BPSN is a valid and
reliable tool for assessing pain in preterm and full-term
neonates. Due to feedback from clinical experts concern-
ing difficulties in pain assessment in extremely preterm
neonates and the increasing scientific evidence that
indicates neonates’ pain reaction is influenced by indi-
vidual contextual factors [1], we assumed that we will
find a difference in pain reaction depending especially
on neonates’ GA. Furthermore, we hypothesized only a
low-to-moderate association between behavioural and
physiological indicators of pain.
Methods
Sample and settings
This was a prospective multisite validation study with
repeated measurement design. It was conducted in three
university hospital NICUs in Switzerland (Basel, Bern
and Zurich). The study was approved by the Ethics
Committee Bern, the Ethics Committee northwest/cen-
tral Switzerland, and the Ethics Committee Zurich. Re-
cruitment and data collection were ongoing, from
January 1 to December 31, 2016. Data collection was ex-
tended in Bern until January 31, 2017, because we
needed to recruit more extremely premature neonates.
We included premature neonates born between 24 0/7
and 36 6/7 weeks of gestation, if they were expected to
undergo 2–5 routine capillary heel sticks in their first
14 days of life. We included full-term neonates born be-
tween 37 0/7 and 42 0/7 weeks of gestation, if they were
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expected to have at least two routine capillary heel sticks
during their first 14 days of life. We needed parental per-
mission to include preterm and full-term neonates. We
excluded neonates if they had had a high-grade intraven-
tricular haemorrhage (grades III and IV), if they had a
severe life-threatening malformation or suffered from
any condition that caused partial or total loss of sensitiv-
ity, if they had an arterial cord pH < 7.15 at birth, if they
had surgery for any reason, or if they had a congenital
malformation that affected brain circulation and/or car-
diovascular system.
Recruitment and data collection procedures
Neonates were recruited by consecutive sampling and
then stratified according to GA at birth [27]. Trained
study assistants in each study centre identified poten-
tially eligible neonates and informed their parents of the
aim and purpose of the study. After parents granted
written informed consent, trained study assistants video-
taped neonates (using a HC-V757 high-definition cam-
corder manufactured by Panasonic, Osaka, Japan) during
their next 1–5 routine capillary heel sticks. For each heel
stick, we produced three video sequences: baseline, heel
stick, and recovery phases. Each video sequence began
by focusing on the face of the neonate for at least 1 mi-
nute to allow adequate assessment of facial activity and
cry. Thereafter, the infant’s body was recorded for at
least 1 minute. Bedside nurses were asked not to handle
the neonates before the baseline phase was recorded, to
avoid additional distress that could change the measure-
ment. During the heel stick procedure, the neonates
were lying in their incubator (or crib) and the position
of the infants was unchanged for the video recording.
The baseline phase was recorded 2 to 3min before the
beginning of the heel stick procedure. Afterwards, the
bedside nurse warmed the neonate’s heel and gave the
infant a dose of 24% oral sucrose (0.2 ml/kg bodyweight)
to relieve pain [28]. When the nurse disinfected the neo-
nate’s heel, the recording of the heel stick phase began.
First, the neonate’s face was recorded, until the nurse
finished the heel stick procedure, which lasted at least a
minute. Then the infant’s body was recorded for at least
one more minute. The recovery phase began immedi-
ately after the heel stick phase was recorded. During
each phase of the heel stick procedure, our study assis-
tants recorded the infant’s highest heart rate and lowest
oxygen saturation measurement from the infant’s moni-
tors, which tracked this data continuously.
Each video sequence was checked for quality and digit-
ally elaborated by trained study assistants in Final Cut
Pro X [29] video editing software. We removed any in-
formation that could have revealed the heel stick phase
to the raters to ensure continued blindness. The video
sequences were uploaded onto a web-based rating tool
developed for our study. Uploaded sequences were ran-
domized by sequence number, phase, and presentation
order. Five nurses who were working in a NICU and
were experienced in using the BPSN (Mean = 8.3 years
of experience, SD = 6.1, Range = 3.5–15 years) retrieved
the video sequences from the web-based platform and
independently rated the behavioural pain expression of
the neonates using the BPSN and the PIPP-R. The
nurses were trained to use and score the PIPP-R.
Measures
Pain reaction was measured with the BPSN [24] and the
PIPP-R [26]. Each of the nine items of the BPSN is rated
on a 4-point Likert scale (0, 1, 2, and 3), and then the
scores are summed. On the BPSN total score, which in-
cludes seven subjective items (i.e., sleeping, crying, con-
solation, skin colour, facial expression, posture, and
breathing), and two physiological items (i.e., changes in
heart rate and oxygen saturation), the scores of 11 or
more points indicate pain (BPSN total scores range from
0 to 27). In a first validation study in the year 2004 [24],
the BPSN showed good construct validity among neo-
nates with GAs between 27 and 41 weeks (n = 12); BPSN
scores were significantly higher during painful (M =
15.96, SD = 5.7) compared to non-painful (M = 2.32, SD
= 1.6, p < 0.001) situations. Furthermore, the correlations
between the BPSN and the Visual Analog Scale (VAS; r
= 0.855, p < 0.0001) and the PIPP (r = 0.907, p < 0.0001)
were high, as well as the interrater (r = 0.86–0.97) and
intrarater reliability (r = 0.98–0.99) of the BPSN [24]. In
our study, five independent blinded raters watched the
videos to rate the seven subjective items. Both physio-
logical indicators were captured from the neonate’s
monitoring records during video recordings. Because the
raw data on heart rate, oxygen saturation and breathing
rate in the baseline phase was used to calculate differ-
ences during the heel stick and recovery phases, we set
the baseline scores of these items to zero, and retro-
spectively converted the raw data between baseline, heel
stick, and recovery phase into BPSN scores that ranged
between 0 and 3.
The PIPP-R is a well validated pain assessment tool for
use with premature and full-term neonates, widely used in
North America in clinics and for research [16, 26, 30, 31].
The PIPP-R includes three behavioural indicators (brow
bulge, eye squeeze, and naso-labial furrow) and two
physiological indicators (heart rate and oxygen saturation).
Each indicator is rated on a 4-point Likert scale (0, 1, 2,
and 3). The PIPP-R accounts for GA and baseline behav-
ioural state as contextual factors. Neonates with younger
GAs and neonates in quiet sleep state score the highest,
but they are only factored in if the infant’s behavioural and
physiological sub score is ≥1 [26]. Zero points indicate no
pain or perhaps no response to pain, 1–6 points indicate
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low pain, 7–12 points indicate moderate pain, and ≥ 13 se-
vere pain. Total PIPP-R scores range from 0 to 21 for neo-
nates with GA < 28weeks in a quiet and sleep baseline
behavioural state, and from 0 to 15 for full-term neonates
in an active and awake baseline behavioural state [26].
The PIPP-R shows beginning construct validity [30];
PIPP-R scores were significantly higher during painful (M
= 6.7, SD = 3.0) compared to non-painful (M = 4.8, SD =
2.9; p < 0.001) procedures among full-term and preterm
neonates with GAs as young as 26 weeks of gestation (n =
202). In addition, the PIPP-R showed good interrater reli-
ability between nurses and pain experts (R2 = 0.87–0.92; p
< 0.001), and nurses reported that the PIPP-R is a feasible
and appropriate pain assessment tool [30]. In our study,
both physiological indicators were captured from the neo-
nate’s monitoring records and converted into PIPP-R scale
values like the physiological indicators of the BPSN. The
behavioural indicators and behavioural state were rated
from the videos by the same five independent raters. We
calculated interrater reliability of the three behavioural
items with a two-way random-effects, absolute agreement,
single measure model that ranged from 0.750 to 0.842
(Mdn = 0.803) in the heel stick phases of the five measure-
ment points.
We retrieved individual contextual factors retrospect-
ively from patient charts [27] and will publish a separate
paper describing their influence on the variability of pain
reaction across repeated measurement points.
Sample size and power
Our target sample size of 150 neonates was based on an
a priori power analysis of the hypothesized association
between the BPSN and GAs at baseline. That analysis
was based on data from a previous study (n = 71; [32])
and a descriptive-explorative analysis (n = 23); it as-
sumed a Type I error probability of 5%, a power of 80%,
and at least three documented baseline heel sticks per
study infant.
Data analysis
Factor analyses explored the structure of the BPSN
and measurement invariance. Psychometric tests ex-
amined interrater reliability, internal consistency, con-
struct validity, concurrent validity with the PIPP-R
[30], association between behavioural and physio-
logical items, and sensitivity and specificity. Because
the sample was heterogeneous, we also conducted
analyses for different GA-groups. We used the statis-
tics programs SPSS [33] and R [34] for all analyses.
Space restriction limit us to reporting mainly our re-
sults from the heel stick phases. In this comprehen-
sive validation study, we did multiple testing of
outcome data arising from individual neonates. Cor-
rection of p-values with Bonferroni adjustment [35]
would not have rendered findings non-significant.
Therefore, all p-values are presented uncorrected for
multiple testing unless otherwise specified. A p-value
< 0.05 was considered statistically significant.
Preliminary analyses
Exploratory analyses described the data and looked for
anomalies that could reduce the validity of the data ana-
lysis. We used descriptive and frequency statistics to de-
scribe sample characteristics and each rater’s pain
scores.
Missing values
We analysed the ratings of the 1′817 video sequences
for the volume and pattern of missing data, since single
items of the BPSN and the PIPP-R could be rated
“non-evaluable”. Because it is impossible to compute
BPSN and PIPP-R sum scores when an item was not
rated, we used multiple imputation [36] and the
R-package partykit [37] to derive those scores by re-
placing the values of non-rated items with random sub-
stitutes generated from conditional inference regression
trees [38]. We generated five data sets, so there were five
variants on the BPSN and PIPP-R sum scores.
Interrater reliability
Intraclass correlation coefficients (ICCs) and their 95%
confidence intervals were calculated to determine inter-
rater reliability of the seven subjective BPSN-items [39,
40]. Since pain reaction of a neonate is rated by a single
nurse in the clinical setting, and pain level scores were
central to our outcome, we assessed interrater reliability
with a two-way random-effects, absolute agreement, sin-
gle measure model [41]. ICC coefficients were also cal-
culated with a two-way random-effects, absolute
agreement, average measure model, to generate more in-
formation about the reliability of the mean ratings pro-
vided by the five raters [40]. Each phase of the five
measurement points was analysed separately, resulting
in 120 ICC coefficients (8 rating scores * 3 phases * 5
measurement points) per model.
Factor analyses
Measurement construct
Multiple group longitudinal confirmatory factor analysis
[42] was used to evaluate the extent to which individual
items correlated with the unobservable pain construct,
the predictive performance of the construct, and
whether factor loadings were invariant across time and
raters. The R-package lavaan [43] was used for this ana-
lysis. Full maximum likelihood estimates were based on
the assumption that data were missing at random.
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Model specification
Figures 1 and 2 show the structures of our confirmatory
factor analysis (CFA) models for the subjective and
physiological subscales. For item selection, we used only
data from the heel stick phases of the five measurement
points. Measurement invariance tests were based on
data from all phases (baseline, heel stick, and recovery)
and all measurement points (t1-t5).
The longitudinal structure of the data was accounted
for by implementing covariances between factors (Fig. 3,
structure of the subjective subscale). The covariance
structure of factors for the physiological subscale or add-
itional phases or measurement points was implemented
as shown.
For the subjective subscale, we stacked the data re-
cords of raters, and used the rater as a grouping variable.
This specification of this model made it impossible to
model covariances between values of the same child
measured by different raters. We chose this specification
because it did allow us to test invariance of model pa-
rameters within and across raters.
Analytical procedure
We selected items to improve the fit of the CFA model.
At estimation, to remove inconsistent items, we re-
stricted loadings of a given item to a common value
across raters and measurement points. For both sub-
scales, we estimated several model configurations with
at least two items, resulting, for the subjective subscale
with 7 items, in 120 models. For the physiological sub-
scale, we used only one model since it included only two
items. Selecting the final model was a three-step process.
First, we excluded several models with loadings < 0.3
and also excluded models with root mean square errors
of approximation (RMSEA) > 0.06, Comparative Fit Indi-
ces (CFI; [44]) < 0.95 and Tucker-Lewis Indices < 0.95
(TLI; [45]). The minimal loading size of 0.3 was inspired
by Brown [46], and the combinations of cut-offs for the
RMSEA, CFI and TLI were inspired by Hu and Bentler
[47, 48]. Second, we chose from the remaining models
those with the highest number of parameters because
we wanted to keep as many appropriate items as pos-
sible. Third, we planned to select the model with the
highest CFI if Step 2 left us with more than one candi-
date, but this step turned out to be unnecessary. We
found no suitable factor model for the physiological sub-
scale and therefore, we used regression analysis to pick
the item most sensitive to pain.
We continued factor analysis by examining measure-
ment invariance across time points within-raters and
overall measurement invariance. Only loading (weak) in-
variance was considered, because other parameters like
intercepts and variances could be expected to vary over
time and phases. Measurement invariance was examined
with Satorra and Bentler’s likelihood ratio test [49] and
tests based on the RMSEA, CFI and TLI that used
Cheung and Rensvold’s critical values [50].
Reliability and validity of the modified BPSN
The results of our factor analyses showed that only the
behavioural items crying, facial expression, and posture
had consistently high factor loadings over time. The
physiological items heart rate and oxygen saturation did
not load on a common factor and did not correlate with
each other. Further analyses showed that the item heart
rate was more sensitive to pain than oxygen saturation.
We thus decided to exclude the items sleeping, consola-
tion, skin colour, breathing, and oxygen saturation from
the BPSN. In following examinations, we used a modi-
fied version of the BPSN that included facial expression,
crying, and posture, as a behavioural subscale, and heart
rate as an additional physiological indicator. Because the
results of the measurement invariance analyses showed
that the measurement construct measured with the
modified behavioural subscale works differently for dif-
ferent raters, we accounted for differences between the
raters by either including the raters in the model, or by
Facial Expression
Breathing
Consolation
Crying
Posture
Skin Colour
Sleeping
Subjective Subscale
Fig. 1 The structure of the factor model used for the subjective subscale of the BPSN
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conducting separate analyses for each rater and then
pooling the results.
Internal consistency and corrected item-total correlation
We evaluated the internal consistency of the modified
version of the behavioural subscale that included items
facial expression, crying and posture by calculating
Cronbach’s α. We calculated corrected item-total corre-
lations to analyse correlations between single items and
the behavioural subscale. In addition, we calculated the
resulting Cronbach’s Alpha when an individual item is
removed from the scale (Cronbach’s Alpha if Item De-
leted) [51]. Data from each rater were analysed separ-
ately, resulting in 75 analyses (5 raters * 3 phases * 5
measurement points), and then we used cocron [52], a
web interface, to statistically compare the Cronbach’s
Alpha coefficients calculated for each rater.
Correlations between behavioural and physiological
indicators of pain
Pearson product-moment correlation coefficients were
calculated to establish the association between the modi-
fied behavioural subscale of the BPSN and heart rate.
Data from each rater were analysed separately, resulting
in 50 analyses (5 raters * 2 phases * 5 measurement
points). Afterwards, for each phase we examined at each
measurement point whether the correlation coefficients
calculated for the five raters were statistically different,
using the χ2-statistics of Steiger [53].
Construct validity
We compared the level of pain scores between the three
phases (baseline, heel stick and recovery) to determine
construct validity of the BPSN. We analysed the modified
behavioural subscale and heart rate in a linear mixed effect
analysis that used the R-package lme4 [54]. Linear mixed
effect analysis allowed us to control variance created by
multiple measurement points per subject [55]. The three
phases, five measurement points, GA at time of birth, and
gender were fixed effects in the model. Neonates and
raters were random intercepts. Likelihood Ratio Tests
tested the effect of the three phases on the level of pain
scores [55].
Concurrent validity
Pearson product-moment correlation coefficients were
calculated to establish concurrent validity between the
modified total scores of the BPSN (facial expression, cry-
ing, posture, heart rate) and the PIPP-R. Separate ana-
lysis were performed for the data of each rater, resulting
in 75 analyses (5 raters * 3 phases * 5 measurement
points), and afterwards, we examined for each phase at
each measurement point if the correlation coefficients
calculated for the five raters were not statistically differ-
ent, again using the χ2-test of Steiger [53].
Specificity and sensitivity analysis
A Receiver-Operating Characteristic (ROC) curve ana-
lysis was used to evaluate the ability of the modified
BPSN total score to detect pain in neonates and to de-
termine the cut-off value that maximized both sensitivity
and specificity [56]. The PIPP-R was the reference value
that allowed us to determine sensitivity and specificity;
PIPP-R values of ≤6 characterized neonates as experien-
cing no or low pain; values ≥7 characterized neonates as
experiencing moderate to severe pain. We tested
whether the area under the curve (AUC) was greater
than 0.5 and calculated sensitivity and specificity of the
Heart Rate
Oxygen Saturation
Physiological Subscale
Fig. 2 The structure of the factor model used for the physiological subscale of the BPSN
Subjective 
Subscale
t1
Subjective 
Subscale
t2
Subjective 
Subscale
t3
Subjective 
Subscale
t4
Subjective 
Subscale
t5
Fig. 3 Specified covariances between factors
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BPSN by using the cut-off values the ROC curve sug-
gested. We performed this analysis separately for the
heel stick phases of the five measurement points and the
five raters, resulting in 25 ROC curves analysis (5 raters
* 5 measurement points), and we averaged the values
calculated for each rater.
Secondary analyses by GA-groups
Infants that ranged from 24 2/7 to 42 5/7 GA at time of
birth were included in the primary analyses. Because the
sample was heterogenous, we reanalysed the data separ-
ately for four GA-groups [57]: extremely preterm neo-
nates (24 0/7–27 6/7 weeks GA); very preterm neonates
(28 0/7–31 6/7 weeks GA); moderate to late preterm ne-
onates (32 0/7–36 6/7 weeks GA); and, full-term neo-
nates (37 0/7–42 6/7 weeks GA). Analyses remained the
same with exception of the factor and linear mixed
model analyses. We could not reanalyse the factor ana-
lysis for different GA-groups separately because the
sub-samples were too small. In the linear mixed model
analyses, GA was already considered as a fixed effect.
We did not use Bonferroni adjustment in this subgroup
analyses because we exploratively analysed if there were
any obvious differences between the four GA-groups.
Results
Missing data and sample characteristics
We enrolled a total of 162 neonates in the study; 8 were
excluded from data analysis because video sequences
were missing or of poor quality. Figure 4 illustrates the
flow of recruitment and data collection.
For the five raters, ≤ 1.0% data was missing for the
BPSN items sleeping, crying, consolation, skin colour
and posture; for facial expression, 0.1 to 4.0% (Mdn =
0.8%) data was missing, and for breathing, 0.3 to 8.7%
(Mdn = 1.9%) was missing. For the PIPP-R, 0.5 to
3.3% (Mdn = 1.0%) of data was missing for brow
bulge, 0.4 to 3.6% (Mdn = 0.7%) for eye squeeze, 0.6
to 28.3% (Mdn = 4.3%) for naso-labial furrow, and 0.1
to 0.9% (Mdn = 0.4%) for behavioural state. Less than
1% of data was missing for the physiological items
heart rate and oxygen saturation.
Mean GA at birth of the total sample was 30.85 (SD =
4.5) weeks and ranged from 24.29 to 41.57. Demo-
graphic and medical characteristics of the sample are
summarized in Table 1.
Results of descriptive and preliminary analysis
Means of the BPSN total-scale, subjective subscale, and
items are summarized in Table 2. Physiological items are
Fig. 4 Flow diagram of the recruitment and data collection process
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not included in this table because they were captured
from the neonates’ monitoring records during video re-
cordings and the raw data was retrospectively converted
into BPSN scores between 0 and 3. The mean scores for
heart rate ranged from 0.47 to 0.76 (Mdn = 0.72) during
the five heel stick phases, and from 0.03 to 0.11 (Mdn =
0.09) during the five recovery phases. The mean scores
for oxygen saturation ranged from 0.77 to 1.25 (Mdn =
0.86) during the five heel stick phases, and from 0.51 to
0.71 (Mdn = 0.61) during the five recovery phases.
Interrater reliability
We derived the results of our interrater reliability ana-
lyses by calculating two-way random-effects, absolute
agreement models. The results are summarized in
Table 3. We again excluded heart rate and oxygen satur-
ation. Interrater agreement for the items crying, consola-
tion, facial expression, and posture tended to decrease
across the five measurement points.
Factor analyses
Item selection
First, we used all items and heel stick phases of the five
measurement points to estimate the multiple group con-
firmatory factor models for the subjective and physio-
logical subscale. No parameter restrictions were applied,
so that loadings could vary across measurement points
and raters. To compare the loadings of all items, we re-
stricted factor variance to 1. Figure 5 shows the esti-
mated factor loadings of the model for the subjective
subscale and Fig. 6 for the physiological subscale. For
the subjective subscale, loadings for breathing (range =
− 0.167-0.110) and skin colour (range = − 0.034-0.293)
are low, while loadings for sleeping vary widely between
raters (range = 0.096–0.982). Loadings of the remaining
items, consolation, crying, facial expression, and pos-
ture, seem consistent, but they tend to decrease over
time. Rater D’s loadings often conflict with other raters
and vary over time.
For the physiological subscale, two loadings exceed by
far a value of 1, indicating poor fit between model and
data. Additional analyses showed no association between
heart rate and oxygen saturation. Pearson product-mo-
ment correlations between heart rate and oxygen satur-
ation ranged from r = − 0.028 to 0.106 (Mdn = 0.017; p >
0.05) during the heel stick phases of the five measurement
points. Large loadings are probably numerical artefacts
and should not be over-interpreted. Because the physio-
logical items did not load on a common factor or correlate
with each other, we discarded all but one of the physio-
logical items based on their sensitivity to pain. We ana-
lysed the sensitivity to pain of heart rate and oxygen
saturation by calculating linear mixed effect models (see
next section).
Table 1 Demographic and medical characteristics of the total sample and the four gestational age groups
Gestational age groups
Total Sample Extremely preterm
neonates
Very preterm
neonates
Moderate to late
preterm neonates
Full-term
neonates
Sample, n (%) 154 (100) 50 (32.5) 45 (29.2) 38 (24.7) 21 (13.6)
Sex, n (%)
- Male 87 (56.5) 31 (62.0) 23 (51.1) 20 (52.6) 13 (61.9)
GA at birth in weeks, mean (SD) 30.85 (4.5) 26.23 (1.2) 29.44 (1.0) 34.21 (1.0) 38. 81 (1.3)
Birth weight in grams, mean (SD) 1630.10 (934.3) 851.40 (196.4) 1285.11 (328.2) 2093.68 (377.5) 3384.52 (811.6)
Number of comorbidities, mean (SD) 5.70 (4.4) 10.06 (4.2) 5.44 (2.4) 2.66 (1.4) 1.38 (1.1)
CRIB score, mean (SD) 3.76 (3.9) 7.50 (3.7) 3.24 (2.8) 1.05 (1.7) 0.86 (1.6)
Way of delivery, n (%)
- Vaginal-spontan 36 (23.4) 10 (20.0) 4 (8.9) 13 (34.2) 9 (42.9)
- Vaginal-operativ 4 (2.6) 0 (0) 1 (2.2) 2 (5.3) 1 (4.8)
- Planned c-section 23 (14.9) 3 (6.0) 8 (17.8) 7 (18.4) 5 (23.8)
- Emergency c-cection 91 (59.1) 37 (74.0) 32 (71.1) 16 (42.1) 6 (28.6)
Number of birth, mean (SD)
- Single 104 (67.5) 43 (86.0) 20 (44.4) 21 (55.3) 20 (95.2)
- One of twins 44 (28.6) 4 (8.0) 22 (48.9) 17 (44.7) 1 (4.8)
- One of triplet 6 (3.9) 3 (6.0) 3 (6.7) 0 (0) 0 (0)
Day of life at first measure point, mean (SD) 3.95 (2.0) 4.80 (2.2) 3.56 (1.9) 3.18 (1.0) 4.19 (2.6)
Note. CRIB Clinical Risk Index for Babies
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We selected items of the subjective subscale by esti-
mating several configural models with at least two items.
In contrast to the model presented in Fig. 5, we re-
stricted factor loadings of a given item to a common
value across time points and raters. We excluded models
with factor loadings < 0.3, a RMSEA > 0.06 and CFI and
TLI < 0.95. This left us with four models, from which we
selected the model with the highest number of items.
Our final model included only the items crying, facial
expression and posture. Table 4 compares model fit indi-
ces of the baseline model with all items to the final
model with only crying, facial expression, and posture.
Table 2 Means of the Bernese Pain Scale for Neonates total-scale and the subjective subscale and items
Rater A Rater B Rater C Rater D Rater E
Phase Means t1-t5 Means t1-t5 Means t1-t5 Means t1-t5 Means t1-t5
Range (Median) Range (Median) Range (Median) Range (Median) Range (Median)
BPSN total-scale Baseline 0.89–1.14 (1.06) 1.99–2.47 (2.21) 1.31–1.51 (1.38) 4.44–5.15 (4.98) 4.66–4.97 (4.80)
N = 81–142 Heel Stick 4.03–4.77 (4.14) 5.98–6.98 (6.33) 4.57–5.41 (4.87) 8.15–9.53 (8.29) 8.00–9.07 (8.52)
Recovery 1.84–2.30 (2.19) 3.08–3.40 (3.22) 2.37–2.67 (2.46) 5.27–6.27 (6.06) 5.37–5.99 (5.65)
Subjective subscale Baseline 0.89–1.14 (1.06) 1.99–2.47 (2.21) 1.31–1.51 (1.38) 4.44–5.15 (4.98) 4.66–4.97 (4.80)
N = 82–142 Heel Stick 2.51–2.82 (2.68) 4.64–4.96 (4.73) 3.00–3.35 (3.31) 6.59–7.47 (6.84) 6.65–7.04 (6.90)
Recovery 1.17–1.63 (1.45) 2.39–2.76 (2.51) 1.70–1.97 (1.77) 4.59–5.60 (5.28) 4.66–5.26 (4.94)
Sleeping Baseline 0.23–0.28 (0.23) 0.39–0.43 (0.41) 0.42–0.51 (0.47) 1.04–1.28 (1.19) 0.89–1.10 (1.05)
N = 95–143 Heel Stick 0.39–0.45 (0.42) 0.75–0.91 (0.89) 0.55–0.63 (0.60) 1.19–1.29 (1.23) 1.35–1.46 (1.41)
Recovery 0.20–0.32 (0.30) 0.40–0.49 (0.41) 0.41–0.51 (0.42) 1.02–1.31 (1.19) 0.89–1.08 (1.06)
Crying Baseline 0.02–0.06 (0.06) 0.04–0.09 (0.07) 0.04–0.10 (0.06) 0.06–0.11 (0.09) 0.07–0.12 (0.09)
N = 96–143 Heel Stick 0.21–0.30 (0.24) 0.30–0.43 (0.36) 0.31–0.42 (0.37) 0.35–0.47 (0.42) 0.36–0.48 (0.43)
Recovery 0.02–0.06 (0.03) 0.03–0.10 (0.06) 0.03–0.11 (0.07) 0.05–0.11 (0.06) 0.04–0.12 (0.09)
Consolation Baseline 0.02–0.06 (0.05) 0.05–0.10 (0.09) 0.04–0.12 (0.07) 0.77–1.07 (0.97) 0.03–0.12 (0.08)
N = 96–143 Heel Stick 0.21–0.32 (0.21) 0.31–0.48 (0.43) 0.28–0.43 (0.33) 1.19–1.48 (1.26) 0.35–0.55 (0.46)
Recovery 0.00–0.07 (0.02) 0.03–0.13 (0.06) 0.01–0.15 (0.09) 0.68–0.99 (0.85) 0.02–0.14 (0.11)
Skin colour Baseline 0.02–0.06 (0.04) 1.00–1.27 (1.11) 0.02–0.06 (0.03) 0.86–1.06 (0.97) 1.51–1.67 (1.61)
N = 96–143 Heel Stick 0.05–0.08 (0.07) 1.19–1.29 (1.26) 0.03–0.05 (0.03) 0.99–1.36 (1.07) 1.55–1.79 (1.69)
Recovery 0.00–0.06 (0.04) 1.05–1.18 (1.13) 0.02–0.04 (0.03) 0.89–1.09 (1.04) 1.48–1.69 (1.53)
Facial expression Baseline 0.16–0.29 (0.24) 0.17–0.29 (0.19) 0.22–0.32 (0.25) 0.73–0.86 (0.75) 0.83–0.89 (0.87)
N = 95–143 Heel Stick 0.50–0.64 (0.61) 0.61–0.69 (0.64) 0.60–0.65 (0.63) 1.01–1.13 (1.06) 1.08–1.18 (1.12)
Recovery 0.19–0.33 (0.24) 0.09–0.19 (0.17) 1.16–0.26 (0.23) 0.62–0.79 (0.69) 0.80–0.89 (0.87)
Posture Baseline 0.33–0.49 (0.40) 0.27–0.36 (0.30) 0.45–0.49 (0.48) 0.93–1.04 (0.99) 1.15–1.29 (1.19)
N = 97–143 Heel Stick 0.55–0.67 (0.60) 0.69–0.80 (0.78) 0.57–0.71 (0.70) 1.17–1.24 (1.20) 1.38–1.45 (1.41)
Recovery 0.32–0.43 (0.34) 0.20–0.34 (0.32) 0.37–0.46 (0.41) 0.80–0.94 (0.87) 1.06–1.20 (1.19)
Breathing Heel Stick 0.47–0.57 (0.50) 0.32–0.65 (0.54) 0.61–0.72 (0.65) 0.50–0.69 (0.64) 0.39–0.62 (0.47)
N = 84–142 Recovery 0.35–0.54 (0.45) 0.31–0.46 (0.40) 0.40–0.63 (0.58) 0.49–0.64 (0.53) 0.31–0.58 (0.41)
Raw Scores Baseline 26.7–27.9 (27.6) 25.7–26.9 (25.8) 27.8–29.5 (28.1) 26.0–26.9 (26.6) 28.4–30.1 (29.5)
Breathing Heel Stick 28.6–29.2 (28.5) 26.1–27.8 (27.0) 28.2–29.9 (28.9) 27.2–28.3 (27.5) 29.4–30.4 (30.0)
N = 91–142 Recovery 27.0–28.7 (27.7) 25.3–27.1 (26.2) 27.4–29.3 (28.3) 26.4–27.4 (26.6) 28.9–30.1 (29.7)
Note. N = number of neonates included in the analysis. This number varies because of differences in the amount of missing data between the raters at each
measurement point and differences in the number of neonates included at each point of measurement
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This improves the CFI and the TLI indices from about
0.8 to 0.95.
Physiological items’ sensitivity to pain
Because the factor analysis indicated that the physio-
logical items heart rate and oxygen saturation do not fit
the data well, we next examined these items for their
sensitivity to pain. We calculated linear mixed models
that included the variables phases, measurement points,
GA at time of birth, and gender as fixed effects, and ne-
onates as random intercept. We used Likelihood Ratio
Tests to compare a model without the heel stick and re-
covery phases to a model that included the phases.
There was a significant effect of phase on heart rate
(χ2(5) = 172.91, p < 0.001). Heart rate scores during
the recovery phases were, on average, 0.646 point
lower than scores during the heel stick phases (SE =
0.09, t-value = − 7.383). Phase also significantly af-
fected oxygen saturation (χ2(5) = 33.658, p < 0.001).
Oxygen saturation scores were, on average, 0.258
points lower during the recovery phases than during
the heel stick phases (SE = 0.12, t-value = − 2.136). We
Table 3 Intraclass Correlation Coefficients and their 95% confident intervals for the single items of the Bernese Pain Scale for Neonates
Heel Stick Phase 1 Heel Stick Phase 2 Heel Stick Phase 3 Heel Stick Phase 4 Heel Stick Phase 5
ICC [95%CI] ICC [95%CI] ICC [95%CI] ICC [95%CI] ICC [95%CI]
Sleeping
N 135 139 117 105 93
Single measures 0.215 [0.13–0.31] 0.267 [0.18–0.36] 0.211 [0.13–0.30] 0.185 [0.11–0.28] 0.221 [0.13–0.33]
Average measures 0.578 [0.43–0.69] 0.646 [0.52–0.74] 0.572 [0.43–0.69] 0.532 [0.37–0.66] 0.586 [0.43–0.71]
Crying
N 138 140 117 107 94
Single measures 0.773 [0.72–0.82] 0.694 [0.63–0.76] 0.721 [0.65–0.78] 0.719 [0.65–0.78] 0.655 [0.57–0.73]
Average measures 0.945 [0.93–0.96] 0.919 [0.89–0.94] 0.928 [0.90–0.95] 0.927 [0.90–0.95] 0.905 [0.87–0.93]
Consolation
N 140 140 117 108 94
Single measures 0.453 [0.31–0.58] 0.381 [0.22–0.53] 0.420 [0.27–0.55] 0.319 [0.16–0.48] 0.257 [0.11–0.41]
Average measures 0.805 [0.69–0.87] 0.755 [0.58–0.85] 0.784 [0.65–0.86] 0.701 [0.48–0.82] 0.634 [0.38–0.78]
Skin colour
N 141 138 115 108 96
Single measures 0.074 [0.02–0.14] 0.049 [0.03–0.37] 0.073 [0.02–0.15] 0.045 [0.00–0.10] 0.072 [0.01–0.15]
Average measures 0.285 [0.09–0.45] 0.205 [0.03–0.37] 0.284 [0.08–0.46] 0.189 [0.01–0.36] 0.280 [0.06–0.47]
Facial expression
N 135 130 112 102 92
Single measures 0.655 [0.53–0.75] 0.555 [0.43–0.66] 0.558 [0.45–0.66] 0.500 [0.37–0.62] 0.514 [0.37–0.64]
Average measures 0.905 [0.85–0.94] 0.862 [0.79–0.91] 0.863 [0.80–0.91] 0.833 [0.75–0.89] 0.841 [0.74–0.90]
Posture
N 141 139 117 108 97
Single measures 0.551 [0.38–0.68] 0.487 [0.31–0.63] 0.536 [0.38–0.66] 0.400 [0.25–0.54] 0.342 [0.21–0.48]
Average measures 0.860 [0.75–0.92] 0.826 [0.69–0.89] 0.852 [0.75–0.91] 0.769 [0.62–0.85] 0.722 [0.57–0.82]
Breathing
N 119 111 100 95 82
Single measures 0.252 [0.17–0.34] 0.348 [0.26–0.44] 0.334 [0.24–0.44] 0.348 [0.25–0.45] 0.402 [0.30–0.51]
Average measures 0.627 [0.51–0.72] 0.727 [0.64–0.80] 0.715 [0.62–0.79] 0.727 [0.63–0.81] 0.770 [0.68–0.84]
Raw Scores Breathing
N 128 123 107 106 91
Single measures 0.636 [0.56–0.71] 0.632 [0.56–0.71] 0.674 [0.59–0.75] 0.610 [0.53–0.69] 0.630 [0.54–0.71]
Average measures 0.897 [0.87–0.92] 0.896 [0.86–0.92] 0.912 [0.88–0.94] 0.887 [0.85–0.92] 0.895 [0.86–0.93]
Note. ICC = Intraclass Correlation Coefficients, calculated with two-way random-effects, absolute agreement models; [95% CI] = 95% confident intervals of the ICCs
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thus decided to use only heart rate for the physio-
logical subscale.
Measurement invariance
Measurement invariance was examined only for the sub-
jective subscale, since the physiological subscale con-
tained one item. In this analysis, we re-estimated the
final model that included crying, facial expression and
posture. We used different parameter restrictions: (Free)
= all parameters are free; (WRLInv) = within-rater load-
ings invariance was assumed by restricting loadings of
items across time but not across raters; (OLInv) = overall
loadings invariance was assumed by restricting loadings
across time and across raters. We already applied the
OLInv assumption to select items. We next asked if the
restricted models fit the data as well as the unrestricted
models, and whether factor loadings are (partially) in-
variant. We performed the same analysis but used only
data from the heel stick phase of the five measurement
points. Then we used data from all phases and measure-
ment points. Table 5 shows differences between fit indi-
ces of the unrestricted and restricted models, including
the likelihood ratio test. At a 5% significance level, the
zero hypothesis of equal fit or loadings invariance is not
rejected for within-rater invariance when we used only
data from the heel stick phases, but it was otherwise
rejected, most sharply for overall loading invariance
(OLInv).
Differences between the fit indices RMSEA, CFI and
TLI yield different test results. Using the 1% level
rejection areas [50] for the RMSEA, measurement in-
variance is rejected when the difference is > 0.013, for
the CFI, it is rejected when it is < − 0.0085, and, for the
TLI, when it is < − 0.0078. Accordingly, within-rater
loadings invariance (WRLInv) is never rejected, but
overall measurement invariance (OLInv) is always
rejected with CFI and TLI, and never with RMSEA.
The tests strongly suggest that the pain measurement
construct under consideration works differently for dif-
ferent raters. For within-rater invariance, invariance is
not rejected during the heel stick phases; for all data, it
is rejected by the χ2-test but not by RMSEA, CFI and
TLI. We may assume approximate invariance, while
keeping in mind the results.
Reliability and validity of the modified BPSN
Our factor analysis and analysis of the physiological
items’ sensitivity to pain led us to adopt a modified ver-
sion of the BPSN for our next analyses. The modified
BPSN includes a behavioural subscale (facial expression,
crying, and posture) and adds heart rate as a pain
indicator.
Cronbach’s alpha and corrected item-Total correlation
Cronbach’s Alpha, corrected item-total correlation coeffi-
cients and the resulting Alpha when an individual item is
removed from the scale (Alpha if Item Deleted) for the
modified behavioural subscale are summarized in Table 6.
During the heel stick phases of the five measurement
points, Cronbach’s Alpha coefficients of the five raters
Fig. 5 Factor loadings of the baseline factor models for the subjective subscale
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differed significantly (p < 0.01). Internal consistency of the
behavioural subscale tended to decrease over time.
Correlations between behavioural and physiological
indicators of pain
We examined the associations between behavioural and
physiological indicators of pain with the modified behav-
ioural subscale of the BPSN including the items crying,
facial expression, and posture, and the physiological item
heart rate. See Table 7 for the correlation coefficients of
these analyses. At measurement point 3, the correlation
coefficients differed significantly between the five raters
(p = 0.008), while the correlation coefficients were ap-
proximately the same during the other measurement
points (p > 0.05). When we considered a Bonferroni
adjusted p-value (p < 0.05/10), none of the correlation
coefficients would differ significantly between the five
raters.
Construct validity
To determine construct validity of the BPSN, we com-
pared levels of pain scores of the modified behavioural
subscale between the three phases. The residual variance
of this analysis was σ2 = 1.708 (SD = 1.307); variances of
the random effects were σ2 = 0.354 (SD = 0.595) for neo-
nates and σ2 = 0.391 (SD = 0.625) for raters. Phases sig-
nificantly affected the level of behavioural pain scores
(χ2(10) = 864.18, p < 0.001). Behavioural pain scores in
the heel stick phases averaged 1.04 higher than pain
scores in the baseline phases, and 1.13 higher than pain
scores in the recovery phases. More results are summa-
rized in Table 8. The same analysis was performed for
the item heart rate (Table 8). The residual variance of
this analysis was σ2 = 0.588 (SD = 0.767) and variance
of the random effect neonates was σ2 = 0.037
(SD = 0.191). GA at time of birth significantly affected
behavioural pain scores (SE = 0.01, t = 5.488) and heart
rate (SE = 0.01, t = 6.145). Gender had no effect on
behavioural pain scores (SE = 0.10, t = − 0.170) or on
heart rate (SE = 0.05, t = 0.051).
Concurrent validity
We examined the concurrent validity between the modi-
fied total score of the BPSN and the PIPP-R. See Table 9
for the correlation coefficients of these analyses. The
correlation coefficients of the five raters were the same
in about half of the cases. They differed significantly at
measurement point 1 (p = 0.010) and measurement point
4 (p = 0.045). With a Bonferroni adjusted p-value
(p < 0.05/15), none of the correlation coefficients differed
significantly between the five raters.
Sensitivity and specificity
The results of the ROC analyses to examine sensitivity
and specificity of the modified BPSN total score (includ-
ing crying, facial expression, posture, and heart rate) are
shown in Table 10. During the heel stick phases of the
five measurement points, a cut-off of 1.5 points fits best
to reach a sensitivity of approximately 80% and a specifi-
city of similar accuracy.
Results of the psychometric testing of the BPSN
separated by GA-groups
Interrater reliability
ICCs coefficients of the four different GA-groups are
summarized in Table 11. Interrater reliability of the
items facial expression, posture and consolation tended
to improve as GA increases.
Fig. 6 Factor loadings of the baseline factor models for the
physiological subscale
Table 4 Fit indices of the Baseline and Final Models differ by item inclusions
Model df χ2 AIC RMSEA CFI TLI SRMR
Baseline (7 subjective items) 2918 4985 36,875 0.068 0.807 0.803 0.135
Final (Crying, Facial expression, Posture) 472 648 13,575 0.049 0.961 0.957 0.111
Note. Model indices: df = degrees of freedom; AIC = Akaike Information Criterion; RMSEA = root mean squared error of approximation; CFI = Bentler’s Comparative
Fit Index; TLI = Tucker-Lewis Indices; SRMR = standardized root mean square residual
Schenk et al. BMC Pediatrics           (2019) 19:20 Page 12 of 21
Internal consistency of the modified behavioural BPSN
subscale
Cronbach’s Alpha calculated separately for the four
GA-groups, are summarized in Table 12. Most Cron-
bach’s Alpha coefficients were in the range of acceptable
to excellent [58] during the heel stick phases of the five
measurement points.
Correlations between behavioural and physiological
indicators of pain
During the heel stick phases of the five measurement
points and among the five raters, correlations between
the modified behavioural subscale of the BPSN and the
item heart rate ranged from r = −0.173-0.577 (Mdn =
0.196) among extremely preterm neonates, from r =
0.024–0.480 (Mdn = 0.329) among very preterm neo-
nates, from r = − 0.174-0.442 (Mdn = 0.172) among mod-
erate to late preterm neonates, and from r = − 0.044 to
0.402 (Mdn = 0.236) among full-term neonates.
Concurrent validity
During the heel stick phases of the five measurement
points and among the five raters, correlations between
the total scale of the modified BPSN and the PIPP-R
ranged from r = 0.560–0.775 (Mdn = 0.683) among ex-
tremely preterm neonates, from r = 0.582–0.875 (Mdn =
0.750) among very preterm neonates, from r = 0.603–
0.860 (Mdn = 0.769) among moderate to late preterm
neonates, and from r = 0.757–0.898 (Mdn = 0.808)
among full-term neonates.
Sensitivity and specificity
The results of the ROC analyses to examine sensitivity
and specificity of the modified BPSN total scale separ-
ately for each GA-group are provided in Table 13. We
found cut-off points needed to increase along with GA
to reach about 80% sensitivity and similarly high
specificity.
Discussion
After rigorous statistical testing, we significantly reduced
the number of items in the original BPSN, leaving only
three behavioural items: facial expression, crying, and
posture. We included only one physiological item, heart
rate, in the new version. Psychometric properties of
these four items indicate convincing validity across all
GA groups, but GA should be considered in pain assess-
ment because different GA-groups require different
cut-off points.
Factor structure and reliability of the BPSN
The factor analysis showed that a model that includes
the items crying, facial expression, and posture fits the
data best. In fact, facial expression, crying, and body
movement are widely studied indicators for pain assess-
ment in neonates and are considered the most sensitive
behavioural indicators of pain [4, 59, 60].
Facial expression is considered the most reliable and
sensitive indicator for pain assessment in both preterm
and full-term neonates [4]. Facial expressions extremely
preterm neonates are likely to show include brow bulge,
eye squeeze, nasolabial furrow, and vertical mouth
stretch [20]. The BPSN more generally assesses facial ex-
pression, which aids in assessing preterm infants who
wear CPAP masks and tapes to fix tubes to the skin,
which can make it difficult to assess specific components
of expression, like nasolabial furrow. The PIPP-R item
nasolabial furrow was the least frequently rated item in
our study, often because it was obscured by CPAP masks
or tapes.
Crying is a common pain response in neonates and is
included in several pain scales (e.g., [27, 61–63]), but
some have questioned crying as an indicator of pain be-
cause it cannot be assessed in some neonates [21, 59].
Mechanical ventilation, inhibiting drugs, severe illness,
and other reasons may limit the ability to cry. Although
crying is not specific to pain [59], it may be the first in-
dication a caregiver has that an infant is in pain [64].
Preterm neonates with immature facial muscles are less
able to communicate their pain through facial expres-
sions, so crying can alert their caregivers [17].
Several pain assessment tools include one or more
items that assess body movements (e.g., [9, 61, 65, 66].
Holsti, Grunau, Oberlander and Whitfield [67] analysed
behavioural pain reaction of early preterm neonates with
the Newborn Individualized Development Care and As-
sessment Program (NIDCAP). They found that neonates
flexed and extended their arms and legs, put their hands
Table 5 Difference statistics for measurement invariance testing
Model Restriction df Δ RMSEA Δ CFI Δ TLI Δχ2 Δ df p (Δχ2)
Heel stick phases of measurement points t1-t5 WRLInv 440 0 0.000 0.002 39 40 0.531
OLInv 448 0 − 0.015 − 0.015 115 48 0.000
All phases and measurement points WRLInv 4340 0 −0.007 − 0.006 123 40 0.000
OLInv 4348 0 −0.024 − 0.025 343 48 0.000
Note. WRLInv = within-rater loadings invariance; OLInv = overall loadings invariance; df = degrees of freedom; RMSEA = root mean squared error of approximation;
CFI = Bentler’s Comparative Fit Index; TLI = Tucker-Lewis Indices; Δχ2 = Satorra-Bentler 2010 χ2-test statistic
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Table 8 Results of the linear mixed modelling analysis for the modified behavioural Bernese Pain Scale for Neonates-subscale and
heart rate
Behavioural Subscale
Likelihood Ratio Test χ2 df p-value
Phases 864.18 10 < 0.001
Fixed effects Estimated coefficients Std. Error t-value
Intercept 0.265 0.458 0.579
Baseline phase −1.041 0.069 −15.008
Recovery phase −1.134 0.069 −16.040
Measurement point 2 − 0.130 0.070 −1.852
Measurement point 3 0.079 0.074 1.077
Measurement point 4 − 0.078 0.076 −1.038
Measurement point 5 0.097 0.079 1.238
GA at time of birth 0.063 0.012 5.488
Gender (female) −0.017 0.101 −0.170
Measurement point 2 * Baseline 0.251 0.099 2.538
Measurement point 2 * Recovery 0.309 0.098 3.140
Measurement point 3 * Baseline 0.147 0.104 1.419
Measurement point 3 * Recovery 0.071 0.103 0.682
Measurement point 4 * Baseline 0.308 0.106 2.919
Measurement point 4 * Recovery 0.354 0.105 3.359
Measurement point 5 * Baseline 0.062 0.109 0.569
Measurement point 5 * Recovery 0.067 0.109 0.614
Item Heart rate
Likelihood Ratio Test χ2 df p-value
Phases 172.91 5 < 0.001
Fixed effects Estimated coefficients Std. Error t-values
Intercept −0.563 0.221 −2.547
Recovery phase −0.646 0.088 −7.383
Measurement point 2 0.023 0.089 0.260
Measurement point 3 −0.199 0.093 −2.139
Measurement point 4 −0.141 0.095 −1.477
Measurement point 5 0.117 0.099 1.183
GA at time of birth 0.042 0.007 6.145
Gender (female) 0.003 0.054 0.051
Measurement point 2 * Recovery 0.021 0.126 0.167
Measurement point 3 * Recovery 0.206 0.131 1.578
Measurement point 4 * Recovery 0.155 0.133 1.160
Measurement point 5 * Recovery −0.032 0.138 −0.231
Note. χ2 = Chi-square value; df = degrees of freedom; N = 154. Bonferroni adjusted p-value < 0.025
Table 7 Pearson product-moment correlation coefficients of the correlations between the modified behavioural Bernese Pain Scale
for Neonates-subscale and heart rate
Heel Stick Phase 1 Heel Stick Phase 2 Heel Stick Phase 3 Heel Stick Phase 4 Heel Stick Phase 5
N 144 140 118 109 97
Median (Range) 0.316* (0.237–0.329*) 0.235 (0.183–0.285) 0.234 (0.102–0.327*) 0.188 (0.155–0.251) 0.305 (0.223–0.379*)
Note. Median =Median of the Pearson product-moment correlation calculated for each rater separately; * Bonferroni adjusted p-value < 0.001
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on their faces, fisted, and finger splayed more often dur-
ing the heel stick procedure. Morison et al. [68] found
neonates with lower GA at birth made more specific
body movements but had less facial expression at 32
weeks post-conceptional age, which suggests assessing
body movements could provide useful supplementary in-
formation about preterm neonates. The BPSN more
generally assesses body movement by evaluating a neo-
nate’s posture on a 4-point Likert-scale, ranging from re-
laxed body to permanent tension. Our results suggest
that posture is a sensitive indicator for assessing pain
across GA-groups.
We found that heart rate and oxygen saturation did
not load on a common physiological factor or correlate
with each other. Because heart rate was more sensitive
to pain and more strongly associated with the three be-
havioural indicators of pain, we included heart rate in
the new version of the BPSN. The results of our analyses
confirm previous findings that correlations between
behavioural and physiological indicators of pain were
low [69–71], behavioural indicators were more sensitive
to pain than physiological indicators [69, 72], and heart
rate was more sensitive to pain than oxygen saturation
[71].
Though factor loadings of crying, facial expression,
and posture did not vary within raters during the heel
stick phases, they did vary between raters. This result
suggests that different raters assess pain differently, an
assumption further supported by the results of our inter-
rater reliability analysis. There was good to excellent
interrater agreement on crying, but agreement on facial
expression and posture ranged from poor to good [73],
depending on the measurement point and the model to
calculate ICCs. The differences in interrater reliability
could be explained by differences in the way raters de-
fined the items. Crying may be a more objective and reli-
able item than facial expression or posture because it
considers duration. Improving the guidelines and train-
ing for applying the BPSN may improve interrater
agreement.
The first validation study of the BPSN [24] used Cron-
bach’s Alpha reliability coefficient to calculate interrater
reliability, and found interrater reliability of the subjective
subscale of the BPSN (r = 0.77–0.97) was high. Cronbach’s
Alpha determines if the ratings of two or more persons
are consistent, but it does not measure absolute agree-
ment [74]. Since the cut-off differentiates between a pain-
ful and non-painful state, agreement between nurses and
other caregivers about an infant’s level of pain is crucial.
We thus decided to use the more stringent absolute agree-
ment model to calculate interrater reliability.
Interrater agreement and factor loadings of the items
crying, facial expression, consolation, and posture tended
to decrease over time. Cronbach’s Alpha and corrected
item-total correlations of the items crying, facial expres-
sion, and posture tended to decrease too. This accords
with the results of another study that showed high
within-subject variability among preterm neonates’ pain
reaction across repeated measurement points [75].
Interrater reliability was high during the heel sticks
1–3 and decreased during heel sticks 4–5. These find-
ings cannot be explained by rater fatigue, because the
video sequences were analysed in random order. The
variability in pain reactions might be explained by the
Table 10 Results of the ROC analyses for the modified Bernese
Pain Scale for Neonates total score
Cut-off points AUC
Heel stick phase N 0.5 1.5 2.5 [95% CI]
t1 144
Sensitivity 0.926 0.853 0.724 0.863
Specificity 0.515 0.662 0.857 [0.800–0.926]
t2 140
Sensitivity 0.908 0.811 0.667 0.825
Specificity 0.442 0.597 0.805 [0.756–0.894]
t3 118
Sensitivity 0.874 0.769 0.631 0.812
Specificity 0.424 0.672 0.858 [0.734–0.890]
t4 109
Sensitivity 0.870 0.750 0.574 0.812
Specificity 0.484 0.685 0.876 [0.730–0.894]
t5 97
Sensitivity 0.869 0.794 0.646 0.812
Specificity 0.383 0.670 0.879 [0.722–0.902]
Note. The PIPP-R was the reference value, with a cut-off point of 6.5 that
discriminated between no/low pain (≤ 6 points) and moderate to high pain (≥
7 points); AUC = Area under the curve; [95% CI] = 95% confidence intervals of
the AUC; the results were originally computed separately for each rater and
aggregated assuming normal distribution of the parameters; bold-set font =
cut-offs with sensitivity and specificity nearest 80%
Table 9 Pearson product-moment correlation coefficients of the correlations between the total scores of the modified Bernese Pain
Scale for Neonates and the PIPP-R
Heel Stick Phase 1 Heel Stick Phase 2 Heel Stick Phase 3 Heel Stick Phase 4 Heel Stick Phase 5
N 144 140 118 109 97
Median (Range) 0.697** (0.652**-0.758**) 0.709** (0.662**-0.735**) 0.688** (0.649-**0.723**) 0.666** (0.636**-0.735**) 0.648** (0.600**-0.711**)
Note. Correlation coefficients were calculated for the heel stick phases of the five measurement points (t1-t5); Median =Median of the Pearson product-moment
correlation coefficients that were calculated separately for each rater; **p < 0.01; * p < 0.05
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influence of individual contextual factors and needs
to be investigated [1, 2, 20, 21].
Validity of the modified BPSN
The modified BPSN that includes crying, facial expres-
sion, posture, and heart rate showed good construct val-
idity and concurrent validity with the PIPP-R. Pain
scores on the behavioural subscale averaged more than
one point higher during the heel stick than during the
baseline and recovery phases. Pain scores on heart rate
averaged 0.65 points higher during the heel stick phase
than during the recovery phase. Neonates’ GA at time of
birth influenced their pain scores. With every additional
week of GA, pain scores on the behavioural subscale
(crying, facial expression, posture) increased about 0.063
points. If we apply this result on our study sample
with a wide range of GAs (24 2/7–42 5/7 weeks of
GA), behavioural pain reaction of the neonate with
Table 11 Intraclass Correlation Coefficients for the subjective Bernese Pain Scale for Neonates-items calculated with two-way
random-effects, absolute agreement models
Extremely Preterm
Neonates
Very Preterm
Neonates
Moderate to Late
Preterm Neonates
Full-term Neonates
Heel Stick Phases t1-t5
Range (Median)
Heel Stick Phases t1-t5
Range (Median)
Heel Stick Phases t1-t5
Range (Median)
Heel Stick Phases
t1-t5 Range
Sleeping
N 41–47 32–44 20–34 14–20
Single measures 0.175–0.310 (0.260) 0.145–0.356 (0.198) 0.090–0.289 (0.160) 0.155–0.225
Average measures 0.515–0.692 (0.637) 0.459–0.734 (0.553) 0.330–0.670 (0.487) 0.478–0.592
Crying
N 40–47 33–44 21–35 14–20
Single measures 0.622–0.794 (0.701) 0.538–0.786 (0.716) 0.564–0.783 (0.702) 0.619–0.680
Average measures 0.892–0.951 (0.921) 0.854–0.948 (0.926) 0.866–0.948 (0.922) 0.890–0.914
Consolation
N 40–47 33–44 21–35 14–20
Single measures 0.227–0.281 (0.257) 0.216–0.565 (0.390) 0.374–0.598 (0.469) 0.389–0.684
Average measures 0.595–0.661 (0.634) 0.579–0.866 (0.761) 0.749–0.881 (0.815) 0.761–0.915
Skin colour
N 41–48 34–44 21–36 13–19
Single measures 0.010–0.058 (0.051) 0.002–0.104 (0.062) 0.057–0.166 (0.069) 0.071–0.080
Average measures 0.049–0.236 (0.211) 0.011–0.367 (0.248) 0.230–0.498 (0.271) 0.276–0.302
Facial expression
N 41–46 31–40 20–34 13–19
Single measures 0.392–0.514 (0.436) 0.498–0.698 (0.526) 0.438–0.748 (0.601) 0.616–0.817
Average measures 0.763–0.841 (0.794) 0.832–0.921 (0.847) 0.796–0.937 (0.883) 0.889–0.957
Posture
N 42–48 34–44 21–35 14–20
Single measures 0.333–0.479 (0.420) 0.369–0.501 (0.472) 0.286–0.685 (0.519) 0.576–0.795
Average measures 0.714–0.821 (0.783) 0.745–0.834 (0.817) 0.667–0.916 (0.839) 0.872–0.951
Breathing
N 36–41 29–37 17–35 9–14
Single measures 0.019–0.378 (0.287) 0.313–0.507 (0.371) 0.158–0.419 (0.314) 0.171–0.317
Average measures 0.090–0.752 (0.669) 0.695–0.837 (0746) 0.485–0.783 (0.696) 0.508–0.699
Breathing Raw Scores
N 39–45 32–40 19–35 11–14
Single measures 0.508–0.680 (0.618) 0.530–0.637 (0.587) 0.655–0.780 (0.681) 0.558–0.664
Average measures 0.838–0.914 (0.890) 0.850–0.898 (0.876) 0.905–0.947 (0.914) 0.863–0.908
Note. N = Number of observations per measurement point
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the highest GA was about 1.13 points higher than
pain reaction of the neonate with the lowest GA.
Heart rate of the neonate with the highest GA was
also about 0.76 points higher than heart rate of the
neonate with the lowest GA. Like other studies that
analysed the relationship between gender and pain re-
action in neonates (e.g., [76–78]), we found gender
had no effect on the level of pain scores.
Sensitivity and specificity of the modified BPSN
The results of the sensitivity and specificity analyses sug-
gest that a cut-off of 1.5 points (total overall score = 12
points) would discriminate between no to low pain and
moderate to high pain (measured with the PIPP-R). For
the original BPSN scale, the cut-off was much higher, at
10.5 points (total overall score = 27 points). We found
that the mean of the BPSN total scale that included nine
Table 13 Results of the ROC analyses for the modified Bernese Pain Scale for Neonates total score, separated for GA-groups
Heel Stick Phases of Measurement Points t1-t5
AUC Cut-off Sensitivity Specificity
Range (Median) points Range (Median) Range (Median)
Extremely Preterm Neonates 0.707–0.878 (0.801)
N = 42–48 0.5 0.734–0.875 (0.839) 0.398–0.562 (0.538)
1.5 0.637–0.765 (0.666) 0.691–0.853 (0.713)
2.5 0.410–0.594 (0.494) 0.901–0.970 (0.945)
Very Preterm Neonates 0.810–0.930 (0.852)
N = 34–44 0.5 0.849–0.970 (0.905) 0.284–0.606 (0.439)
1.5 0.745–0.901 (0.811) 0.638–0.728 (0.680)
2.5 0.596–0.785 (0.648) 0.864–0.977 (0.902)
Moderate to Late Preterm Neonates 0.874–0.941 (0.927)
N = 21–37 1.5 0.900–0.990 (0.970) 0.564–0.660 (0.581)
2.5 0.763–0.950 (0.897) 0.705–0.832 (0.787)
3.5 0.532–0.763 (0.675) 0.879–0.975 (0.933)
Full-term Neonates 0.893–0.906
N = 14–20 2.5 0.942–0.959 0.419–0.664
3.5 0.807–0.888 0.808–0.824
4.5 0.714–0.831 0.836–0.896
5.5 0.423–0.751 0.892–0.969
Note. The PIPP-R was the reference value, with a cut-off point of 6.5 that discriminated between no/low pain (≤ 6 points) and moderate to high pain (≥ 7 points);
AUC = Area under the curve; [95% CI] = 95% confidence intervals of the AUC; the results were originally computed separately for each rater and aggregated
assuming normal distribution of the parameter; Range = heel stick phases of measurement points t1-t5; bold-set font = cut-offs with sensitivity and specificity
nearest 80%
Table 12 Cronbach’s Alpha for the modified behavioural Bernese Pain Scale for Neonates-subscale, separated by GA-groups
Cronbach’s Alpha
Heel Stick Phase 1
Median (Range)
Heel Stick Phase 2
Median (Range)
Heel Stick Phase 3
Median (Range)
Heel Stick Phase 4
Median (Range)
Heel Stick Phase 5
Median (Range)
Extremely preterm neonates 0.819 (0.813–0.894) 0.821 (0.695–0.862) 0.760 (0.720–0.883) 0.796 (0.690–0.841) 0.830 (0.691–0.840)
N = 42–48
Very preterm neonates 0.908 (0.833–0.915) 0.835 (0.787–0.868) 0.800 (0.705–0.878) 0.794 (0.624–0.902) 0.824 (0.708–0.841)
N = 32–44
Moderate to late preterm neonates 0.836 (0.736–0.932) 0.863 (0.724–0.930) 0.892 (0.844–0.924) 0.872 (0.765–0.896) 0.774 (0.576–0.871)
N = 20–36
Full-term neonates 0.909 (0.906–0.964) 0.832 (0.813–0.932)
N = 13–20
Note. Median =Median of the coefficients calculated for each rater separately; Range = Range of the five coefficients calculated for each rater
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items varied widely and depended on the rater, but it did
not reach the cut-off value of 11 points during the heel
stick phases of the five measurement points. The prelim-
inary dose of oral sucrose administered to neonates be-
fore each heel stick may have lowered pain scores in our
study [28]. In the first validation study of the BPSN, neo-
nates received no pain relieving intervention before the
heel stick, and BPSN total scores increased significantly
during the heel stick, averaging 15.96 points (SD = 5.7)
[24]. The relief provided by sucrose should be factored
into the decision about a new cut-off value for the modi-
fied BPSN.
Comparison of different GA-groups
Neonates with younger GA at birth had lower pain
scores than more mature infants. The results of the sep-
arate sensitivity and specificity analyses for the four
GA-groups indicated as GA increases, so should the
cut-off of the BPSN that discriminates between no to
low pain and moderate to high pain (measured with the
PIPP-R). To reach a sensitivity and specificity of ap-
proximately 80%, extremely preterm neonates require a
cut-off value of 0.5 points, very preterm neonates re-
quire 1.5 points, moderate to late preterm neonates re-
quire 2.5 points, and full-term neonates require 3.5
points. Our ROC analysis showed that the modified
BPSN was least able, but still moderately good [41], to
discriminate between neonates who experience no or
low pain and neonates who experience moderate to high
pain in the group of extremely preterm neonates and in-
creases with increasing GA. Extremely preterm neonates’
pain expression may be less apparent because their im-
mature nervous system and facial muscles prevent them
from expressing a robust pain reaction [20, 21, 60, 68].
Understanding the difficulty this poses for accurate pain
assessment in extremely preterm neonates could be
helpful when establishing cut-off values for the BPSN.
Based on our study results, we recommend differentiat-
ing between GA-groups and establishing cut-off values
based on GA. The PIPP-R already includes GA in pain
assessment; the younger the GA, the more points
PIPP-R adds to the pain score [26].
The other analyses we conducted separately for the
four GA-groups showed that concurrent validity of
the modified BPSN total score with the PIPP-R was
highest for full-term neonates (r = 0.814–0.834) and
lowest, but still good, for extremely preterm neonates
(r = 0.631–0.710). Interrater agreement on facial ex-
pression and posture tended to improve as GA
increased.
Limitations
This study is limited, first, by our decision to rate neonates’
pain expression from video sequences. Characteristics of
the videos may have affected the reliability of the ratings
(e.g., poor lighting conditions, quality of the raters’ screen,
position of the neonate, several assistants for video record-
ing). Second, different nurses performed the heel sticks,
and their individual characteristics may have influenced ne-
onates’ pain reaction. Third, particularly during the baseline
and recovery phases, where the scores of the items were
low, floor effects may have influenced our study results. For
example, we considered a variety of extensions of the model
specification in our factor analysis but discarded them be-
cause of convergence problems likely related to floor
effects, when upper categories were almost or completely
left empty. Treating the rating scores as numeric did not re-
solve floor effect problems, or rather the opposite [79], but
allowed to obtain results. Floor effects may also have low-
ered interrater agreement, especially during the baseline
and recovery phases. Fourth, our later hypothesis testing
may be compromised by measurement error caused by low
interrater agreement [40]. We compensated for this pos-
sible problem by either including the raters in the model,
or by conducting separate analyses for each rater and then
pooling the results. Fifth, pain reaction was measured dur-
ing the heel stick, so our results cannot be generalized to
other acute painful procedures or more persistent or
chronic pain. The BPSN is used for routine pain assessment
in NICUs and should therefore be sensitive to repeated and
more prolonged and chronic pain, so future validation stud-
ies should assess and compare the level of pain scores
during different painful situations.
Conclusions
The modified version of the BPSN that includes facial ex-
pression, crying, posture, and heart rate is a promising
tool for assessing acute pain in full-term and preterm neo-
nates across gestational ages, but our results suggest that
adding different cut-off points for different GA-groups
will improve the BPSN’s clinical usefulness.
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